Industry Research Reports
Home > Reports > Service & Software > Global IVD Contract Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global IVD Contract Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-08-01
Pages: 193 Pages
Report ld: 6984762
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
Instrument and integrated system outsourcing contributes more than one-third of modeled market revenue
Reagent control and calibrator manufacturing contributes close to three-tenths of modeled revenue
North America and Europe lead high-complexity instrument and regulated reagent programs
China and Taiwan are major manufacturing bases for rapid diagnostics consumables and point-of-care products
IVD Contract Manufacturing Service Market Size(US$)
CAGR 2026-2032
8.9%
Market Size,2032
USD 33,877
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 20,345 million
Market Forecast in 2032(Value)
US$ 33,877 million
CAGR
8.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global IVD Contract Manufacturing Service market is projected to grow from US$ 18720 million in 2025 to US$ 33877 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
IVD Contract Manufacturing Service refers to third-party development-transfer, industrialization and manufacturing activities performed for in vitro diagnostic product owners, diagnostic brands and medical technology companies. The market primarily covers diagnostic reagents and assay kits, calibrators and controls, lateral-flow tests, molecular diagnostic reagents, microfluidic cartridges, disposable diagnostic consumables, point-of-care readers, laboratory analyzers and related electromechanical systems. Typical service activities include reagent formulation, antibody or protein conjugation, coating and dispensing, lyophilization, filling and finishing, precision molding, microfluidic bonding, cartridge and kit assembly, electronic manufacturing, instrument integration, calibration, packaging and production validation. Engagement models range from build-to-print production and specialized process outsourcing to OEM, ODM and full-service programs integrating design transfer, supply-chain qualification, pilot production and commercial-scale manufacturing. The market focuses on outsourced activities directly associated with converting diagnostic designs and formulations into reproducible, traceable and commercially scalable IVD products under controlled medical-device quality systems.
MARKET TRENDS
IVD Contract Manufacturing Service is moving from fragmented, build-to-print production toward integrated development-transfer and lifecycle manufacturing. Customers increasingly expect suppliers to support design for manufacturability, reagent and cartridge compatibility, process validation, component qualification and commercial ramp-up rather than perform isolated filling or assembly operations. Product architecture is also becoming more integrated as molecular assays, microfluidic cartridges, biosensors, software-enabled readers and automated laboratory instruments combine biological, fluidic, optical and electronic technologies. This favors suppliers capable of coordinating multiple technical disciplines and maintaining stable production over the full platform lifecycle. Regional manufacturing flexibility is becoming another strategic requirement as diagnostic companies seek alternative sourcing, shorter supply chains and manufacturing capacity closer to major regulated markets. The combination of OEM instrument engineering and scalable manufacturing within broader service platforms illustrates the continuing shift toward integrated outsourcing models.
MARKET SEGMENTATION
By Company
- Jabil Inc.
- Flex Ltd.
- Thermo Fisher Scientific Inc.
- Sanmina Corporation
- Merck KGaA
- Celestica Inc.
- Tecan Group Ltd.
- Molex, LLC
- TE Connectivity plc
- STRATEC SE
- Bio-Techne Corporation
- H.U. Group Holdings
- PHC Holdings Corporation
- SEKISUI CHEMICAL CO., LTD.
- Plexus Corp.
- SMC Ltd.
- Benchmark Electronics, Inc.
- Invetech Group
- Planet Innovation Holdings Limited
- LRE Medical GmbH
- Randox Laboratories Ltd.
- Fortis Life Sciences, LLC
- Fapon Biotech Inc.
- BBI Solutions
- Argonaut Manufacturing Services, Inc.
- Life Science Outsourcing, Inc.
- DCN Dx
- Abingdon Health plc
- SCIENION GmbH
- Microcoat Biotechnologie GmbH
- DiaSys Diagnostic Systems GmbH
- EKF Diagnostics Holdings plc
- Operon S.A.
- Future Diagnostics Solutions B.V.
- Uniogen Oy
- JOYSBIO Biotechnology Co., Ltd.
- Assure Tech (Hangzhou) Co., Ltd.
- TaiDoc Technology Corporation
- Firstep Bioresearch, Inc.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Diagnostic Reagents and Assay Kits
- Controls and Reference Materials
- Lateral-flow Tests and Rapid-test Devices
- Microfluidic Cartridges and Disposable Consumables
- Others
Segment by Application
- Central Laboratory Testing
- Point-of-Care Testing
- Home and Self-testing
- Others
Segment by Category
- Build-to-Print Contract Manufacturing
- Technology Transfer and Scale-up Manufacturing
- Full-service CDMO
- Others
Segment by Division
- Immunodiagnostics
- Molecular Diagnostics
- Clinical Chemistry
- Others
MARKET DYNAMICS
Drivers
Growth is supported by the rising complexity of molecular diagnostics, point-of-care systems, home testing and multiplex assays, together with the increasing number of diagnostic developers that possess proprietary technologies but lack regulated manufacturing infrastructure. Outsourcing allows product owners to limit fixed capital expenditure, shorten industrialization schedules and access established quality, engineering and supply-chain capabilities. Regulatory requirements are also increasing the value of qualified suppliers: the US Quality Management System Regulation became effective on February 2, 2026 and incorporates ISO 13485:2016 into the medical-device quality framework, strengthening requirements for controlled processes, risk management and design transfer.
Restraints
Market expansion is constrained by long customer qualification cycles, sensitive technology-transfer requirements and the reluctance of major diagnostic companies to outsource critical formulations, algorithms or proprietary biological materials. Production volumes can be highly uneven because demand depends on regulatory approvals, clinical adoption and the commercial performance of individual diagnostic platforms. Standardized rapid-test and private-label projects face significant price pressure, while specialized biological manufacturing, validation and low-volume instrument production may carry relatively high labor, documentation and quality-control costs. Switching suppliers after regulatory approval can also require revalidation and documentation changes, limiting the addressable opportunity for new entrants.
Opportunities
The most attractive opportunities are concentrated in integrated reagent-cartridge-instrument programs, molecular assay manufacturing, microfluidic consumables, lyophilized reagents, multiplex testing and localized production for regulated markets. Emerging diagnostic companies represent an important customer group because they often require development transfer, pilot lots, registration batches and commercial production from a single partner. Additional opportunities are emerging from second-source programs, manufacturing transfers between regions, product redesign for lower cost and lifecycle support for established diagnostic platforms. Suppliers that can combine biological processing, precision consumables and instrument engineering are positioned to capture a larger share of customer program value.
Challenges
Suppliers must manage contamination risks, biological material variability, component obsolescence, stringent traceability and customer-specific change-control requirements across products with very different manufacturing profiles. Maintaining profitability is difficult when development programs fail to reach commercial scale or when customers require low-volume production with extensive validation and documentation. The industry also faces shortages of experienced quality, assay-transfer and systems-engineering personnel. Regulatory divergence across markets, cybersecurity requirements for connected instruments and dependence on single-source biological or electronic components further increase program complexity and operational risk.
INDUSTRY CHAIN ANALYSIS
The upstream supply chain includes antibodies, antigens, enzymes, nucleic-acid materials, membranes, polymers, microfluidic substrates, sensors, optical components, electronic components, packaging materials and specialized production equipment. Supplier qualification is particularly important because changes in biological reagents, membrane characteristics, plastic resins or electronic components can affect analytical performance and may trigger additional validation. The middle of the chain consists of assay-transfer specialists, reagent manufacturers, lateral-flow and microfluidic producers, precision molders, instrument OEMs and integrated contract manufacturers. Value is created through process knowledge, design for manufacturability, validation, quality documentation, yield improvement, supply-chain control and the ability to move a program from prototype or registration lots into stable commercial production.
Downstream customers include global diagnostic groups, emerging assay developers, life-science companies, pharmaceutical companies developing companion diagnostics and brands supplying laboratories, hospitals, clinics and home-testing channels. Instrument programs generally offer higher absolute project value and longer product lifecycles, while specialist reagent and consumable programs can generate recurring production revenue and stronger process-based customer retention. Profitability depends less on basic assembly labor than on project complexity, manufacturing yield, regulatory responsibility, proprietary process capability and the proportion of engineering and lifecycle services included in the customer contract.
SEGMENT INSIGHTS
By deliverable type, diagnostic instruments and integrated systems represent the largest modeled value pool, accounting for more than one-third of industry revenue because analyzers and point-of-care platforms require extensive engineering, electronics, fluidics, calibration and lifecycle support. Diagnostic reagents, controls and calibrators account for close to three-tenths of modeled revenue and form a more recurring production base. Microfluidic cartridges, molded consumables and rapid diagnostic products together represent approximately one-quarter of the market, although their competitive conditions differ substantially: precision cartridges and biosensor consumables benefit from increasing technical complexity, while standardized lateral-flow private-label manufacturing remains more price-sensitive.
DOWNSTREAM MARKET OPPORTUNITIES
Central laboratories remain the principal destination for complex analyzers, automated systems and high-throughput reagent programs, while decentralized testing is creating broader opportunities in clinics, pharmacies, emergency care and home settings. Point-of-care and home-testing products require compact instruments, stable room-temperature reagents, simple sample handling and high-volume disposable production, creating demand for suppliers that can coordinate assay, cartridge and reader development. Molecular diagnostics, companion diagnostics and multiplex testing offer additional opportunities because emerging developers frequently require external support for technology transfer, registration lots and commercial scale-up. Established diagnostic companies also generate demand through second sourcing, regional localization and redesign of mature platforms to reduce cost or address component obsolescence.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America is the principal high-value demand center for IVD Contract Manufacturing Service, supported by a large diagnostic innovation base, numerous specialist reagent manufacturers and a strong concentration of regulated medical-device contract manufacturers. The region is particularly important for molecular diagnostic reagents, controls, complex instruments and development-transfer services. The implementation of the FDA Quality Management System Regulation from February 2, 2026 reinforces demand for suppliers with established ISO 13485-aligned processes, risk management and inspection readiness.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Diagnostic Reagents and Assay Kits
Controls and Reference Materials
Lateral-flow Tests and Rapid-test Devices
Microfluidic Cartridges and Disposable Consumables
Others
BY APPLICATION，2021-2032(US $ MILLION）
Central Laboratory Testing
Point-of-Care Testing
Home and Self-testing
Others
Europe has a dense base of specialist instrument, immunodiagnostic, microfluidic and lateral-flow suppliers, with Germany, the United Kingdom, Switzerland and Northern Europe playing important roles. Four EUDAMED modules became mandatory on May 28, 2026, increasing the operational importance of device registration, certificate information and supply-chain traceability. China and Taiwan provide substantial capacity in rapid diagnostics, molded consumables, diagnostic materials and point-of-care products, while Southeast Asia is attracting selected regional manufacturing transfers. Japan retains strengths in precision instruments, immunodiagnostics and clinical chemistry. South Korea and India have meaningful IVD production capacity, but their publicly verifiable third-party contract manufacturing bases remain less developed than their branded diagnostic industries.
COMPETITIVE LANDSCAPE ANALYSIS
The market has a layered and moderately fragmented competitive structure. Large global electronics and medical manufacturing groups compete for complex instruments and multinational supply programs through manufacturing scale, procurement capability and regional production networks. Specialist IVD contract manufacturers compete through assay-transfer expertise, biological processing, lyophilization, controls, lateral-flow manufacturing, microfluidics or instrument engineering. Regional OEM and private-label suppliers serve standardized rapid diagnostics and price-sensitive customers, particularly in Asia. Competitive advantage increasingly depends on the ability to integrate reagents, consumables and instruments, support regulatory validation and retain programs throughout the product lifecycle. Strategic transactions have combined instrument development with contract manufacturing and have expanded suppliers from individual technical services into broader outsourcing platforms.
REPORT SCOPE
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global IVD Contract Manufacturing Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
CHAPTER OUTLINE
Chapter 1: Defines the IVD Contract Manufacturing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to IVD Contract Manufacturing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global IVD Contract Manufacturing Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Diagnostic Reagents and Assay Kits
1.2.3 Controls and Reference Materials
1.2.4 Lateral-flow Tests and Rapid-test Devices
1.2.5 Microfluidic Cartridges and Disposable Consumables
1.2.6 Others
1.3 Market Segmentation by Service Model
1.3.1 Global IVD Contract Manufacturing Service Market Size by Service Model, 2021 vs 2025 vs 2032
1.3.2 Build-to-Print Contract Manufacturing
1.3.3 Technology Transfer and Scale-up Manufacturing
1.3.4 Full-service CDMO
1.3.5 Others
1.4 Market Segmentation by Diagnostic Technology Platform
1.4.1 Global IVD Contract Manufacturing Service Market Size by Diagnostic Technology Platform, 2021 vs 2025 vs 2032
1.4.2 Immunodiagnostics
1.4.3 Molecular Diagnostics
1.4.4 Clinical Chemistry
1.4.5 Others
1.5 Market Segmentation by Application
1.5.1 Global IVD Contract Manufacturing Service Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Central Laboratory Testing
1.5.3 Point-of-Care Testing
1.5.4 Home and Self-testing
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global IVD Contract Manufacturing Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global IVD Contract Manufacturing Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global IVD Contract Manufacturing Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global IVD Contract Manufacturing Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Diagnostic Reagents and Assay Kits: Market Share by Key Players
3.3.2 Controls and Reference Materials: Market Share by Key Players
3.3.3 Lateral-flow Tests and Rapid-test Devices: Market Share by Key Players
3.3.4 Microfluidic Cartridges and Disposable Consumables: Market Share by Key Players
3.3.5 Others: Market Share by Key Players
3.4 Global IVD Contract Manufacturing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global IVD Contract Manufacturing Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global IVD Contract Manufacturing Service Market by Service Model
4.2.1 Global Revenue by Service Model (2021-2032)
4.2.2 Global Revenue-Based Market Share by Service Model (2021-2032)
4.3 Global IVD Contract Manufacturing Service Market by Diagnostic Technology Platform
4.3.1 Global Revenue by Diagnostic Technology Platform (2021-2032)
4.3.2 Global Revenue-Based Market Share by Diagnostic Technology Platform (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global IVD Contract Manufacturing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America IVD Contract Manufacturing Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America IVD Contract Manufacturing Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe IVD Contract Manufacturing Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe IVD Contract Manufacturing Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific IVD Contract Manufacturing Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific IVD Contract Manufacturing Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America IVD Contract Manufacturing Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America IVD Contract Manufacturing Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa IVD Contract Manufacturing Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa IVD Contract Manufacturing Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Jabil Inc.
11.1.1 Jabil Inc. Corporation Information
11.1.2 Jabil Inc. Business Overview
11.1.3 Jabil Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.1.4 Jabil Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.1.5 Jabil Inc. IVD Contract Manufacturing Service Revenue by Product in 2025
11.1.6 Jabil Inc. IVD Contract Manufacturing Service Revenue by Application in 2025
11.1.7 Jabil Inc. IVD Contract Manufacturing Service Revenue by Geographic Area in 2025
11.1.8 Jabil Inc. IVD Contract Manufacturing Service SWOT Analysis
11.1.9 Jabil Inc. Recent Developments
11.2 Flex Ltd.
11.2.1 Flex Ltd. Corporation Information
11.2.2 Flex Ltd. Business Overview
11.2.3 Flex Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.2.4 Flex Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.2.5 Flex Ltd. IVD Contract Manufacturing Service Revenue by Product in 2025
11.2.6 Flex Ltd. IVD Contract Manufacturing Service Revenue by Application in 2025
11.2.7 Flex Ltd. IVD Contract Manufacturing Service Revenue by Geographic Area in 2025
11.2.8 Flex Ltd. IVD Contract Manufacturing Service SWOT Analysis
11.2.9 Flex Ltd. Recent Developments
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Corporation Information
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.3.4 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.3.5 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Revenue by Product in 2025
11.3.6 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Revenue by Application in 2025
11.3.7 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service Revenue by Geographic Area in 2025
11.3.8 Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service SWOT Analysis
11.3.9 Thermo Fisher Scientific Inc. Recent Developments
11.4 Sanmina Corporation
11.4.1 Sanmina Corporation Corporation Information
11.4.2 Sanmina Corporation Business Overview
11.4.3 Sanmina Corporation IVD Contract Manufacturing Service Product Features and Attributes
11.4.4 Sanmina Corporation IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.4.5 Sanmina Corporation IVD Contract Manufacturing Service Revenue by Product in 2025
11.4.6 Sanmina Corporation IVD Contract Manufacturing Service Revenue by Application in 2025
11.4.7 Sanmina Corporation IVD Contract Manufacturing Service Revenue by Geographic Area in 2025
11.4.8 Sanmina Corporation IVD Contract Manufacturing Service SWOT Analysis
11.4.9 Sanmina Corporation Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA IVD Contract Manufacturing Service Product Features and Attributes
11.5.4 Merck KGaA IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.5.5 Merck KGaA IVD Contract Manufacturing Service Revenue by Product in 2025
11.5.6 Merck KGaA IVD Contract Manufacturing Service Revenue by Application in 2025
11.5.7 Merck KGaA IVD Contract Manufacturing Service Revenue by Geographic Area in 2025
11.5.8 Merck KGaA IVD Contract Manufacturing Service SWOT Analysis
11.5.9 Merck KGaA Recent Developments
11.6 Celestica Inc.
11.6.1 Celestica Inc. Corporation Information
11.6.2 Celestica Inc. Business Overview
11.6.3 Celestica Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.6.4 Celestica Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.6.5 Celestica Inc. Recent Developments
11.7 Tecan Group Ltd.
11.7.1 Tecan Group Ltd. Corporation Information
11.7.2 Tecan Group Ltd. Business Overview
11.7.3 Tecan Group Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.7.4 Tecan Group Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.7.5 Tecan Group Ltd. Recent Developments
11.8 Molex, LLC
11.8.1 Molex, LLC Corporation Information
11.8.2 Molex, LLC Business Overview
11.8.3 Molex, LLC IVD Contract Manufacturing Service Product Features and Attributes
11.8.4 Molex, LLC IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.8.5 Molex, LLC Recent Developments
11.9 TE Connectivity plc
11.9.1 TE Connectivity plc Corporation Information
11.9.2 TE Connectivity plc Business Overview
11.9.3 TE Connectivity plc IVD Contract Manufacturing Service Product Features and Attributes
11.9.4 TE Connectivity plc IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.9.5 TE Connectivity plc Recent Developments
11.10 STRATEC SE
11.10.1 STRATEC SE Corporation Information
11.10.2 STRATEC SE Business Overview
11.10.3 STRATEC SE IVD Contract Manufacturing Service Product Features and Attributes
11.10.4 STRATEC SE IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Bio-Techne Corporation
11.11.1 Bio-Techne Corporation Corporation Information
11.11.2 Bio-Techne Corporation Business Overview
11.11.3 Bio-Techne Corporation IVD Contract Manufacturing Service Product Features and Attributes
11.11.4 Bio-Techne Corporation IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.11.5 Bio-Techne Corporation Recent Developments
11.12 H.U. Group Holdings
11.12.1 H.U. Group Holdings Corporation Information
11.12.2 H.U. Group Holdings Business Overview
11.12.3 H.U. Group Holdings IVD Contract Manufacturing Service Product Features and Attributes
11.12.4 H.U. Group Holdings IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.12.5 H.U. Group Holdings Recent Developments
11.13 PHC Holdings Corporation
11.13.1 PHC Holdings Corporation Corporation Information
11.13.2 PHC Holdings Corporation Business Overview
11.13.3 PHC Holdings Corporation IVD Contract Manufacturing Service Product Features and Attributes
11.13.4 PHC Holdings Corporation IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.13.5 PHC Holdings Corporation Recent Developments
11.14 SEKISUI CHEMICAL CO., LTD.
11.14.1 SEKISUI CHEMICAL CO., LTD. Corporation Information
11.14.2 SEKISUI CHEMICAL CO., LTD. Business Overview
11.14.3 SEKISUI CHEMICAL CO., LTD. IVD Contract Manufacturing Service Product Features and Attributes
11.14.4 SEKISUI CHEMICAL CO., LTD. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.14.5 SEKISUI CHEMICAL CO., LTD. Recent Developments
11.15 Plexus Corp.
11.15.1 Plexus Corp. Corporation Information
11.15.2 Plexus Corp. Business Overview
11.15.3 Plexus Corp. IVD Contract Manufacturing Service Product Features and Attributes
11.15.4 Plexus Corp. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.15.5 Plexus Corp. Recent Developments
11.16 SMC Ltd.
11.16.1 SMC Ltd. Corporation Information
11.16.2 SMC Ltd. Business Overview
11.16.3 SMC Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.16.4 SMC Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.16.5 SMC Ltd. Recent Developments
11.17 Benchmark Electronics, Inc.
11.17.1 Benchmark Electronics, Inc. Corporation Information
11.17.2 Benchmark Electronics, Inc. Business Overview
11.17.3 Benchmark Electronics, Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.17.4 Benchmark Electronics, Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.17.5 Benchmark Electronics, Inc. Recent Developments
11.18 Invetech Group
11.18.1 Invetech Group Corporation Information
11.18.2 Invetech Group Business Overview
11.18.3 Invetech Group IVD Contract Manufacturing Service Product Features and Attributes
11.18.4 Invetech Group IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.18.5 Invetech Group Recent Developments
11.19 Planet Innovation Holdings Limited
11.19.1 Planet Innovation Holdings Limited Corporation Information
11.19.2 Planet Innovation Holdings Limited Business Overview
11.19.3 Planet Innovation Holdings Limited IVD Contract Manufacturing Service Product Features and Attributes
11.19.4 Planet Innovation Holdings Limited IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.19.5 Planet Innovation Holdings Limited Recent Developments
11.20 LRE Medical GmbH
11.20.1 LRE Medical GmbH Corporation Information
11.20.2 LRE Medical GmbH Business Overview
11.20.3 LRE Medical GmbH IVD Contract Manufacturing Service Product Features and Attributes
11.20.4 LRE Medical GmbH IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.20.5 LRE Medical GmbH Recent Developments
11.21 Randox Laboratories Ltd.
11.21.1 Randox Laboratories Ltd. Corporation Information
11.21.2 Randox Laboratories Ltd. Business Overview
11.21.3 Randox Laboratories Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.21.4 Randox Laboratories Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.21.5 Randox Laboratories Ltd. Recent Developments
11.22 Fortis Life Sciences, LLC
11.22.1 Fortis Life Sciences, LLC Corporation Information
11.22.2 Fortis Life Sciences, LLC Business Overview
11.22.3 Fortis Life Sciences, LLC IVD Contract Manufacturing Service Product Features and Attributes
11.22.4 Fortis Life Sciences, LLC IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.22.5 Fortis Life Sciences, LLC Recent Developments
11.23 Fapon Biotech Inc.
11.23.1 Fapon Biotech Inc. Corporation Information
11.23.2 Fapon Biotech Inc. Business Overview
11.23.3 Fapon Biotech Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.23.4 Fapon Biotech Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.23.5 Fapon Biotech Inc. Recent Developments
11.24 BBI Solutions
11.24.1 BBI Solutions Corporation Information
11.24.2 BBI Solutions Business Overview
11.24.3 BBI Solutions IVD Contract Manufacturing Service Product Features and Attributes
11.24.4 BBI Solutions IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.24.5 BBI Solutions Recent Developments
11.25 Argonaut Manufacturing Services, Inc.
11.25.1 Argonaut Manufacturing Services, Inc. Corporation Information
11.25.2 Argonaut Manufacturing Services, Inc. Business Overview
11.25.3 Argonaut Manufacturing Services, Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.25.4 Argonaut Manufacturing Services, Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.25.5 Argonaut Manufacturing Services, Inc. Recent Developments
11.26 Life Science Outsourcing, Inc.
11.26.1 Life Science Outsourcing, Inc. Corporation Information
11.26.2 Life Science Outsourcing, Inc. Business Overview
11.26.3 Life Science Outsourcing, Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.26.4 Life Science Outsourcing, Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.26.5 Life Science Outsourcing, Inc. Recent Developments
11.27 DCN Dx
11.27.1 DCN Dx Corporation Information
11.27.2 DCN Dx Business Overview
11.27.3 DCN Dx IVD Contract Manufacturing Service Product Features and Attributes
11.27.4 DCN Dx IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.27.5 DCN Dx Recent Developments
11.28 Abingdon Health plc
11.28.1 Abingdon Health plc Corporation Information
11.28.2 Abingdon Health plc Business Overview
11.28.3 Abingdon Health plc IVD Contract Manufacturing Service Product Features and Attributes
11.28.4 Abingdon Health plc IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.28.5 Abingdon Health plc Recent Developments
11.29 SCIENION GmbH
11.29.1 SCIENION GmbH Corporation Information
11.29.2 SCIENION GmbH Business Overview
11.29.3 SCIENION GmbH IVD Contract Manufacturing Service Product Features and Attributes
11.29.4 SCIENION GmbH IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.29.5 SCIENION GmbH Recent Developments
11.30 Microcoat Biotechnologie GmbH
11.30.1 Microcoat Biotechnologie GmbH Corporation Information
11.30.2 Microcoat Biotechnologie GmbH Business Overview
11.30.3 Microcoat Biotechnologie GmbH IVD Contract Manufacturing Service Product Features and Attributes
11.30.4 Microcoat Biotechnologie GmbH IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.30.5 Microcoat Biotechnologie GmbH Recent Developments
11.31 DiaSys Diagnostic Systems GmbH
11.31.1 DiaSys Diagnostic Systems GmbH Corporation Information
11.31.2 DiaSys Diagnostic Systems GmbH Business Overview
11.31.3 DiaSys Diagnostic Systems GmbH IVD Contract Manufacturing Service Product Features and Attributes
11.31.4 DiaSys Diagnostic Systems GmbH IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.31.5 DiaSys Diagnostic Systems GmbH Recent Developments
11.32 EKF Diagnostics Holdings plc
11.32.1 EKF Diagnostics Holdings plc Corporation Information
11.32.2 EKF Diagnostics Holdings plc Business Overview
11.32.3 EKF Diagnostics Holdings plc IVD Contract Manufacturing Service Product Features and Attributes
11.32.4 EKF Diagnostics Holdings plc IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.32.5 EKF Diagnostics Holdings plc Recent Developments
11.33 Operon S.A.
11.33.1 Operon S.A. Corporation Information
11.33.2 Operon S.A. Business Overview
11.33.3 Operon S.A. IVD Contract Manufacturing Service Product Features and Attributes
11.33.4 Operon S.A. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.33.5 Operon S.A. Recent Developments
11.34 Future Diagnostics Solutions B.V.
11.34.1 Future Diagnostics Solutions B.V. Corporation Information
11.34.2 Future Diagnostics Solutions B.V. Business Overview
11.34.3 Future Diagnostics Solutions B.V. IVD Contract Manufacturing Service Product Features and Attributes
11.34.4 Future Diagnostics Solutions B.V. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.34.5 Future Diagnostics Solutions B.V. Recent Developments
11.35 Uniogen Oy
11.35.1 Uniogen Oy Corporation Information
11.35.2 Uniogen Oy Business Overview
11.35.3 Uniogen Oy IVD Contract Manufacturing Service Product Features and Attributes
11.35.4 Uniogen Oy IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.35.5 Uniogen Oy Recent Developments
11.36 JOYSBIO Biotechnology Co., Ltd.
11.36.1 JOYSBIO Biotechnology Co., Ltd. Corporation Information
11.36.2 JOYSBIO Biotechnology Co., Ltd. Business Overview
11.36.3 JOYSBIO Biotechnology Co., Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.36.4 JOYSBIO Biotechnology Co., Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.36.5 JOYSBIO Biotechnology Co., Ltd. Recent Developments
11.37 Assure Tech (Hangzhou) Co., Ltd.
11.37.1 Assure Tech (Hangzhou) Co., Ltd. Corporation Information
11.37.2 Assure Tech (Hangzhou) Co., Ltd. Business Overview
11.37.3 Assure Tech (Hangzhou) Co., Ltd. IVD Contract Manufacturing Service Product Features and Attributes
11.37.4 Assure Tech (Hangzhou) Co., Ltd. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.37.5 Assure Tech (Hangzhou) Co., Ltd. Recent Developments
11.38 TaiDoc Technology Corporation
11.38.1 TaiDoc Technology Corporation Corporation Information
11.38.2 TaiDoc Technology Corporation Business Overview
11.38.3 TaiDoc Technology Corporation IVD Contract Manufacturing Service Product Features and Attributes
11.38.4 TaiDoc Technology Corporation IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.38.5 TaiDoc Technology Corporation Recent Developments
11.39 Firstep Bioresearch, Inc.
11.39.1 Firstep Bioresearch, Inc. Corporation Information
11.39.2 Firstep Bioresearch, Inc. Business Overview
11.39.3 Firstep Bioresearch, Inc. IVD Contract Manufacturing Service Product Features and Attributes
11.39.4 Firstep Bioresearch, Inc. IVD Contract Manufacturing Service Revenue and Gross Margin (2021-2026)
11.39.5 Firstep Bioresearch, Inc. Recent Developments
12 IVD Contract Manufacturing Service Value Chain and Ecosystem Analysis
12.1 IVD Contract Manufacturing Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 IVD Contract Manufacturing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global IVD Contract Manufacturing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global IVD Contract Manufacturing Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global IVD Contract Manufacturing Service Market Size Growth Rate by Service Model, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global IVD Contract Manufacturing Service Market Size Growth Rate by Diagnostic Technology Platform, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global IVD Contract Manufacturing Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global IVD Contract Manufacturing Service Revenue by Region (US$ Million), 2021-2026
Table 7. Global IVD Contract Manufacturing Service Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global IVD Contract Manufacturing Service Revenue by Players (US$ Million), 2021-2026
Table 10. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on IVD Contract Manufacturing Service Revenue, 2025
Table 13. Global IVD Contract Manufacturing Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global IVD Contract Manufacturing Service Companies Headquarters
Table 15. Global IVD Contract Manufacturing Service Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global IVD Contract Manufacturing Service Revenue by Type (US$ Million), 2021-2026
Table 19. Global IVD Contract Manufacturing Service Revenue by Type (US$ Million), 2027-2032
Table 20. Global IVD Contract Manufacturing Service Revenue by Service Model (US$ Million), 2021-2026
Table 21. Global IVD Contract Manufacturing Service Revenue by Service Model (US$ Million), 2027-2032
Table 22. Global IVD Contract Manufacturing Service Revenue by Diagnostic Technology Platform (US$ Million), 2021-2026
Table 23. Global IVD Contract Manufacturing Service Revenue by Diagnostic Technology Platform (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global IVD Contract Manufacturing Service Revenue by Application (US$ Million), 2021-2026
Table 26. Global IVD Contract Manufacturing Service Revenue by Application (US$ Million), 2027-2032
Table 27. IVD Contract Manufacturing Service High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America IVD Contract Manufacturing Service Growth Accelerators and Market Barriers
Table 31. North America IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe IVD Contract Manufacturing Service Growth Accelerators and Market Barriers
Table 33. Europe IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific IVD Contract Manufacturing Service Growth Accelerators and Market Barriers
Table 35. Asia-Pacific IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America IVD Contract Manufacturing Service Investment Opportunities and Key Challenges
Table 37. Central and South America IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa IVD Contract Manufacturing Service Investment Opportunities and Key Challenges
Table 39. Middle East and Africa IVD Contract Manufacturing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Jabil Inc. Corporation Information
Table 41. Jabil Inc. Description and Major Businesses
Table 42. Jabil Inc. Product Features and Attributes
Table 43. Jabil Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Jabil Inc. Revenue Proportion by Product in 2025
Table 45. Jabil Inc. Revenue Proportion by Application in 2025
Table 46. Jabil Inc. Revenue Proportion by Geographic Area in 2025
Table 47. Jabil Inc. IVD Contract Manufacturing Service SWOT Analysis
Table 48. Jabil Inc. Recent Developments
Table 49. Flex Ltd. Corporation Information
Table 50. Flex Ltd. Description and Major Businesses
Table 51. Flex Ltd. Product Features and Attributes
Table 52. Flex Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Flex Ltd. Revenue Proportion by Product in 2025
Table 54. Flex Ltd. Revenue Proportion by Application in 2025
Table 55. Flex Ltd. Revenue Proportion by Geographic Area in 2025
Table 56. Flex Ltd. IVD Contract Manufacturing Service SWOT Analysis
Table 57. Flex Ltd. Recent Developments
Table 58. Thermo Fisher Scientific Inc. Corporation Information
Table 59. Thermo Fisher Scientific Inc. Description and Major Businesses
Table 60. Thermo Fisher Scientific Inc. Product Features and Attributes
Table 61. Thermo Fisher Scientific Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Thermo Fisher Scientific Inc. Revenue Proportion by Product in 2025
Table 63. Thermo Fisher Scientific Inc. Revenue Proportion by Application in 2025
Table 64. Thermo Fisher Scientific Inc. Revenue Proportion by Geographic Area in 2025
Table 65. Thermo Fisher Scientific Inc. IVD Contract Manufacturing Service SWOT Analysis
Table 66. Thermo Fisher Scientific Inc. Recent Developments
Table 67. Sanmina Corporation Corporation Information
Table 68. Sanmina Corporation Description and Major Businesses
Table 69. Sanmina Corporation Product Features and Attributes
Table 70. Sanmina Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Sanmina Corporation Revenue Proportion by Product in 2025
Table 72. Sanmina Corporation Revenue Proportion by Application in 2025
Table 73. Sanmina Corporation Revenue Proportion by Geographic Area in 2025
Table 74. Sanmina Corporation IVD Contract Manufacturing Service SWOT Analysis
Table 75. Sanmina Corporation Recent Developments
Table 76. Merck KGaA Corporation Information
Table 77. Merck KGaA Description and Major Businesses
Table 78. Merck KGaA Product Features and Attributes
Table 79. Merck KGaA Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Merck KGaA Revenue Proportion by Product in 2025
Table 81. Merck KGaA Revenue Proportion by Application in 2025
Table 82. Merck KGaA Revenue Proportion by Geographic Area in 2025
Table 83. Merck KGaA IVD Contract Manufacturing Service SWOT Analysis
Table 84. Merck KGaA Recent Developments
Table 85. Celestica Inc. Corporation Information
Table 86. Celestica Inc. Description and Major Businesses
Table 87. Celestica Inc. Product Features and Attributes
Table 88. Celestica Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Celestica Inc. Recent Developments
Table 90. Tecan Group Ltd. Corporation Information
Table 91. Tecan Group Ltd. Description and Major Businesses
Table 92. Tecan Group Ltd. Product Features and Attributes
Table 93. Tecan Group Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. Tecan Group Ltd. Recent Developments
Table 95. Molex, LLC Corporation Information
Table 96. Molex, LLC Description and Major Businesses
Table 97. Molex, LLC Product Features and Attributes
Table 98. Molex, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. Molex, LLC Recent Developments
Table 100. TE Connectivity plc Corporation Information
Table 101. TE Connectivity plc Description and Major Businesses
Table 102. TE Connectivity plc Product Features and Attributes
Table 103. TE Connectivity plc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. TE Connectivity plc Recent Developments
Table 105. STRATEC SE Corporation Information
Table 106. STRATEC SE Description and Major Businesses
Table 107. STRATEC SE Product Features and Attributes
Table 108. STRATEC SE Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. STRATEC SE Recent Developments
Table 110. Bio-Techne Corporation Corporation Information
Table 111. Bio-Techne Corporation Description and Major Businesses
Table 112. Bio-Techne Corporation Product Features and Attributes
Table 113. Bio-Techne Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Bio-Techne Corporation Recent Developments
Table 115. H.U. Group Holdings Corporation Information
Table 116. H.U. Group Holdings Description and Major Businesses
Table 117. H.U. Group Holdings Product Features and Attributes
Table 118. H.U. Group Holdings Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. H.U. Group Holdings Recent Developments
Table 120. PHC Holdings Corporation Corporation Information
Table 121. PHC Holdings Corporation Description and Major Businesses
Table 122. PHC Holdings Corporation Product Features and Attributes
Table 123. PHC Holdings Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. PHC Holdings Corporation Recent Developments
Table 125. SEKISUI CHEMICAL CO., LTD. Corporation Information
Table 126. SEKISUI CHEMICAL CO., LTD. Description and Major Businesses
Table 127. SEKISUI CHEMICAL CO., LTD. Product Features and Attributes
Table 128. SEKISUI CHEMICAL CO., LTD. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. SEKISUI CHEMICAL CO., LTD. Recent Developments
Table 130. Plexus Corp. Corporation Information
Table 131. Plexus Corp. Description and Major Businesses
Table 132. Plexus Corp. Product Features and Attributes
Table 133. Plexus Corp. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. Plexus Corp. Recent Developments
Table 135. SMC Ltd. Corporation Information
Table 136. SMC Ltd. Description and Major Businesses
Table 137. SMC Ltd. Product Features and Attributes
Table 138. SMC Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. SMC Ltd. Recent Developments
Table 140. Benchmark Electronics, Inc. Corporation Information
Table 141. Benchmark Electronics, Inc. Description and Major Businesses
Table 142. Benchmark Electronics, Inc. Product Features and Attributes
Table 143. Benchmark Electronics, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Benchmark Electronics, Inc. Recent Developments
Table 145. Invetech Group Corporation Information
Table 146. Invetech Group Description and Major Businesses
Table 147. Invetech Group Product Features and Attributes
Table 148. Invetech Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 149. Invetech Group Recent Developments
Table 150. Planet Innovation Holdings Limited Corporation Information
Table 151. Planet Innovation Holdings Limited Description and Major Businesses
Table 152. Planet Innovation Holdings Limited Product Features and Attributes
Table 153. Planet Innovation Holdings Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 154. Planet Innovation Holdings Limited Recent Developments
Table 155. LRE Medical GmbH Corporation Information
Table 156. LRE Medical GmbH Description and Major Businesses
Table 157. LRE Medical GmbH Product Features and Attributes
Table 158. LRE Medical GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 159. LRE Medical GmbH Recent Developments
Table 160. Randox Laboratories Ltd. Corporation Information
Table 161. Randox Laboratories Ltd. Description and Major Businesses
Table 162. Randox Laboratories Ltd. Product Features and Attributes
Table 163. Randox Laboratories Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 164. Randox Laboratories Ltd. Recent Developments
Table 165. Fortis Life Sciences, LLC Corporation Information
Table 166. Fortis Life Sciences, LLC Description and Major Businesses
Table 167. Fortis Life Sciences, LLC Product Features and Attributes
Table 168. Fortis Life Sciences, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 169. Fortis Life Sciences, LLC Recent Developments
Table 170. Fapon Biotech Inc. Corporation Information
Table 171. Fapon Biotech Inc. Description and Major Businesses
Table 172. Fapon Biotech Inc. Product Features and Attributes
Table 173. Fapon Biotech Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 174. Fapon Biotech Inc. Recent Developments
Table 175. BBI Solutions Corporation Information
Table 176. BBI Solutions Description and Major Businesses
Table 177. BBI Solutions Product Features and Attributes
Table 178. BBI Solutions Revenue (US$ Million) and Gross Margin (2021-2026)
Table 179. BBI Solutions Recent Developments
Table 180. Argonaut Manufacturing Services, Inc. Corporation Information
Table 181. Argonaut Manufacturing Services, Inc. Description and Major Businesses
Table 182. Argonaut Manufacturing Services, Inc. Product Features and Attributes
Table 183. Argonaut Manufacturing Services, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 184. Argonaut Manufacturing Services, Inc. Recent Developments
Table 185. Life Science Outsourcing, Inc. Corporation Information
Table 186. Life Science Outsourcing, Inc. Description and Major Businesses
Table 187. Life Science Outsourcing, Inc. Product Features and Attributes
Table 188. Life Science Outsourcing, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 189. Life Science Outsourcing, Inc. Recent Developments
Table 190. DCN Dx Corporation Information
Table 191. DCN Dx Description and Major Businesses
Table 192. DCN Dx Product Features and Attributes
Table 193. DCN Dx Revenue (US$ Million) and Gross Margin (2021-2026)
Table 194. DCN Dx Recent Developments
Table 195. Abingdon Health plc Corporation Information
Table 196. Abingdon Health plc Description and Major Businesses
Table 197. Abingdon Health plc Product Features and Attributes
Table 198. Abingdon Health plc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 199. Abingdon Health plc Recent Developments
Table 200. SCIENION GmbH Corporation Information
Table 201. SCIENION GmbH Description and Major Businesses
Table 202. SCIENION GmbH Product Features and Attributes
Table 203. SCIENION GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 204. SCIENION GmbH Recent Developments
Table 205. Microcoat Biotechnologie GmbH Corporation Information
Table 206. Microcoat Biotechnologie GmbH Description and Major Businesses
Table 207. Microcoat Biotechnologie GmbH Product Features and Attributes
Table 208. Microcoat Biotechnologie GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 209. Microcoat Biotechnologie GmbH Recent Developments
Table 210. DiaSys Diagnostic Systems GmbH Corporation Information
Table 211. DiaSys Diagnostic Systems GmbH Description and Major Businesses
Table 212. DiaSys Diagnostic Systems GmbH Product Features and Attributes
Table 213. DiaSys Diagnostic Systems GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 214. DiaSys Diagnostic Systems GmbH Recent Developments
Table 215. EKF Diagnostics Holdings plc Corporation Information
Table 216. EKF Diagnostics Holdings plc Description and Major Businesses
Table 217. EKF Diagnostics Holdings plc Product Features and Attributes
Table 218. EKF Diagnostics Holdings plc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 219. EKF Diagnostics Holdings plc Recent Developments
Table 220. Operon S.A. Corporation Information
Table 221. Operon S.A. Description and Major Businesses
Table 222. Operon S.A. Product Features and Attributes
Table 223. Operon S.A. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 224. Operon S.A. Recent Developments
Table 225. Future Diagnostics Solutions B.V. Corporation Information
Table 226. Future Diagnostics Solutions B.V. Description and Major Businesses
Table 227. Future Diagnostics Solutions B.V. Product Features and Attributes
Table 228. Future Diagnostics Solutions B.V. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 229. Future Diagnostics Solutions B.V. Recent Developments
Table 230. Uniogen Oy Corporation Information
Table 231. Uniogen Oy Description and Major Businesses
Table 232. Uniogen Oy Product Features and Attributes
Table 233. Uniogen Oy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 234. Uniogen Oy Recent Developments
Table 235. JOYSBIO Biotechnology Co., Ltd. Corporation Information
Table 236. JOYSBIO Biotechnology Co., Ltd. Description and Major Businesses
Table 237. JOYSBIO Biotechnology Co., Ltd. Product Features and Attributes
Table 238. JOYSBIO Biotechnology Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 239. JOYSBIO Biotechnology Co., Ltd. Recent Developments
Table 240. Assure Tech (Hangzhou) Co., Ltd. Corporation Information
Table 241. Assure Tech (Hangzhou) Co., Ltd. Description and Major Businesses
Table 242. Assure Tech (Hangzhou) Co., Ltd. Product Features and Attributes
Table 243. Assure Tech (Hangzhou) Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 244. Assure Tech (Hangzhou) Co., Ltd. Recent Developments
Table 245. TaiDoc Technology Corporation Corporation Information
Table 246. TaiDoc Technology Corporation Description and Major Businesses
Table 247. TaiDoc Technology Corporation Product Features and Attributes
Table 248. TaiDoc Technology Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 249. TaiDoc Technology Corporation Recent Developments
Table 250. Firstep Bioresearch, Inc. Corporation Information
Table 251. Firstep Bioresearch, Inc. Description and Major Businesses
Table 252. Firstep Bioresearch, Inc. Product Features and Attributes
Table 253. Firstep Bioresearch, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 254. Firstep Bioresearch, Inc. Recent Developments
Table 255. Technologies, Platforms and Infrastructure
Table 256. Distributors List
Table 257. Market Trends and Market Evolution
Table 258. Market Drivers and Opportunities
Table 259. Market Challenges, Risks, and Restraints
Table 260. Research Programs/Design for This Report
Table 261. Key Data Information from Secondary Sources
Table 262. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Contract Manufacturing Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Diagnostic Reagents and Assay Kits Product Picture
Figure 3. Controls and Reference Materials Product Picture
Figure 4. Lateral-flow Tests and Rapid-test Devices Product Picture
Figure 5. Microfluidic Cartridges and Disposable Consumables Product Picture
Figure 6. Others Product Picture
Figure 7. Global IVD Contract Manufacturing Service Market Size Growth Rate by Service Model, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Build-to-Print Contract Manufacturing Product Picture
Figure 9. Technology Transfer and Scale-up Manufacturing Product Picture
Figure 10. Full-service CDMO Product Picture
Figure 11. Others Product Picture
Figure 12. Global IVD Contract Manufacturing Service Market Size Growth Rate by Diagnostic Technology Platform, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Immunodiagnostics Product Picture
Figure 14. Molecular Diagnostics Product Picture
Figure 15. Clinical Chemistry Product Picture
Figure 16. Others Product Picture
Figure 17. Global IVD Contract Manufacturing Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 18. Central Laboratory Testing
Figure 19. Point-of-Care Testing
Figure 20. Home and Self-testing
Figure 21. Others
Figure 22. IVD Contract Manufacturing Service Report Years Considered
Figure 23. Global IVD Contract Manufacturing Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 25. Global IVD Contract Manufacturing Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Region (2021-2032)
Figure 27. Global IVD Contract Manufacturing Service Revenue-Based Market Share Ranking (2025)
Figure 28. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 29. Diagnostic Reagents and Assay Kits Revenue-Based Market Share by Player in 2025
Figure 30. Controls and Reference Materials Revenue-Based Market Share by Player in 2025
Figure 31. Lateral-flow Tests and Rapid-test Devices Revenue-Based Market Share by Player in 2025
Figure 32. Microfluidic Cartridges and Disposable Consumables Revenue-Based Market Share by Player in 2025
Figure 33. Others Revenue-Based Market Share by Player in 2025
Figure 34. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Service Model (2021-2032)
Figure 36. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Diagnostic Technology Platform (2021-2032)
Figure 37. Global IVD Contract Manufacturing Service Revenue-Based Market Share by Application (2021-2032)
Figure 38. North America IVD Contract Manufacturing Service Revenue YoY (US$ Million), 2021-2032
Figure 39. North America Top 5 Players IVD Contract Manufacturing Service Revenue (US$ Million) in 2025
Figure 40. North America IVD Contract Manufacturing Service Revenue (US$ Million) by Application (2021-2032)
Figure 41. US IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 42. Canada IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 43. Mexico IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 44. Europe IVD Contract Manufacturing Service Revenue YoY (US$ Million), 2021-2032
Figure 45. Europe Top 5 Players IVD Contract Manufacturing Service Revenue (US$ Million) in 2025
Figure 46. Europe IVD Contract Manufacturing Service Revenue (US$ Million) by Application (2021-2032)
Figure 47. Germany IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 48. France IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 49. U.K. IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 50. Italy IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 51. Russia IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 52. Asia-Pacific IVD Contract Manufacturing Service Revenue YoY (US$ Million), 2021-2032
Figure 53. Asia-Pacific Top 8 Players IVD Contract Manufacturing Service Revenue (US$ Million) in 2025
Figure 54. Asia-Pacific IVD Contract Manufacturing Service Revenue (US$ Million) by Application (2021-2032)
Figure 55. Indonesia IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 56. Japan IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 57. South Korea IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 58. Australia IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 59. India IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 60. Indonesia IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 61. Vietnam IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 62. Malaysia IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 63. Philippines IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 64. Singapore IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 65. Central and South America IVD Contract Manufacturing Service Revenue YoY (US$ Million), 2021-2032
Figure 66. Central and South America Top 5 Players IVD Contract Manufacturing Service Revenue (US$ Million) in 2025
Figure 67. Central and South America IVD Contract Manufacturing Service Revenue (US$ Million) by Application (2021-2032)
Figure 68. Brazil IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 69. Argentina IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 70. Middle East and Africa IVD Contract Manufacturing Service Revenue YoY (US$ Million), 2021-2032
Figure 71. Middle East and Africa Top 5 Players IVD Contract Manufacturing Service Revenue (US$ Million) in 2025
Figure 72. Middle East and Africa IVD Contract Manufacturing Service Revenue (US$ Million) by Application (2021-2032)
Figure 73. GCC Countries IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 74. Israel IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 75. Egypt IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 76. South Africa IVD Contract Manufacturing Service Revenue (US$ Million), 2021-2032
Figure 77. IVD Contract Manufacturing Service Value Chain Mapping
Figure 78. Channels of Distribution (Direct Vs Distribution)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of IVD Contract Manufacturing Service in 2026?
The global market size of IVD Contract Manufacturing Service in 2026 was 20345 Million USD.
What is the annual compound growth rate of the global IVD Contract Manufacturing Service market size from 2026 to 2032?
Which companies rank high in the global IVD Contract Manufacturing Service market?
What was the global market size of IVD Contract Manufacturing Service in 2032?
Which region is expected to have the highest market share?
Related Reports
Global IVD Contract Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global IVD Contract Manufacturing Service market size was US$ 18720 million in 2025 and is forecast to reach a readjusted size of US$ 33877 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-08-01
Pages: 186
USD 4250.00
(Single User License)
IVD Contract Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ 18720 million in 2025 and is projected to reach US$ 33877 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 194
USD 3950.00
(Single User License)
Global IVD Contract Manufacturing Service Market Research Report 2026
The global IVD Contract Manufacturing Service market was valued at US$ 18720 million in 2025 and is anticipated to reach US$ 33877 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 181
USD 2900.00
(Single User License)
Global IVD Contract Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Contract Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)
Global IVD Contract Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Contract Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 152
USD 4900.00
(Single User License)
IVD Contract Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 122
USD 3950.00
(Single User License)
Global IVD Contract Manufacturing Service Market Research Report 2025
The global market for IVD Contract Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
IVD Contract Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 124
USD 3950.00
(Single User License)
Global IVD Contract Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global IVD Contract Manufacturing Service market size was US$ 18720 million in 2025 and is forecast to reach a readjusted size of US$ 33877 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-08-01
Pages: 186
USD 4250.00 (Single User License)IVD Contract Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ 18720 million in 2025 and is projected to reach US$ 33877 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-08-01
Pages: 194
USD 3950.00 (Single User License)Global IVD Contract Manufacturing Service Market Research Report 2026
The global IVD Contract Manufacturing Service market was valued at US$ 18720 million in 2025 and is anticipated to reach US$ 33877 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-08-01
Pages: 181
USD 2900.00 (Single User License)Global IVD Contract Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Contract Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
USD 4250.00 (Single User License)Global IVD Contract Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Contract Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 152
USD 4900.00 (Single User License)IVD Contract Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 122
USD 3950.00 (Single User License)Global IVD Contract Manufacturing Service Market Research Report 2025
The global market for IVD Contract Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
USD 2900.00 (Single User License)IVD Contract Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for IVD Contract Manufacturing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 124
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now